Early surgical intervention in a patient with Kasabach-Merritt phenomenon

B A Drolet1, L A Scott, N B Esterly

  • 1Department of Dermatology, The Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Insights

Early surgery can effectively treat Kasabach-Merritt phenomenon in infants. This condition involves a vascular tumor causing low platelets and clotting issues, but resection offers a good outcome.

Area of Science:

  • Pediatric Surgery
  • Hematology
  • Oncology

Background:

  • Kasabach-Merritt phenomenon (KMP) is a rare condition characterized by a vascular tumor that sequesters platelets and coagulation factors.
  • KMP can lead to severe coagulopathy, including thrombocytopenia, hypofibrinogenemia, and elevated fibrin split products.
  • Diagnosis requires a high index of suspicion in infants presenting with a vascular mass and bleeding diathesis.

Observation:

  • A 3-day-old male infant presented with a firm, 3-cm subcutaneous mass.
  • Laboratory findings revealed thrombocytopenia, decreased fibrinogen, and increased fibrin split products, consistent with KMP.
  • The vascular lesion was surgically resected.

Findings:

  • Complete resection of the vascular lesion was achieved without complications.
  • Post-operative recovery was uneventful, with resolution of the coagulopathy.

Implications:

  • Early surgical intervention is a viable and effective therapeutic strategy for Kasabach-Merritt phenomenon.
  • Prompt diagnosis and management can prevent life-threatening complications associated with KMP.
  • This case highlights the importance of considering surgical resection as a primary treatment option for KMP.

Related Concept Videos